Is Entresto maker Novartis scared of Jardiance’s landmark heart failure win? Not really, exec says aliu Wed, 07/21/2021 – 10:34 More: Is Entresto maker Novartis scared of Jardiance's landmark heart failure win? Not really, exec says Source: fierce
read moreEC has cleared Ryeqo for the treatment of moderate to severe symptoms of uterine fibroids More: Myovant, Gedeon Richter’s uterine fibroids med Ryeqo bags EU approval Source: News
read moreThe Autism Strategy will be backed by nearly £75m in the first year, which includes £40m through the NHS Long Term Plan More: Gov’t reveals new strategy to improve support and care for autistic people Source: News
read moreThe latest funding round was led by Oxford Sciences Innovation More: Orbit Discovery raises .6m to boost peptide drug discovery services Source: News
read moreThe new fund will build upon the Cancer Drugs Fund to fast-track access to promising new treatments More: NHS England unveils new Innovative Medicine Fund Source: News
read moreAlbireo’s rare liver disease drug Bylvay scores back-to-back approvals in U.S., Europe esagonowsky Tue, 07/20/2021 – 17:09 More: Albireo's rare liver disease drug Bylvay scores back-to-back approvals in U.S., Europe Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals